Jos Kosterink
Jos Kosterink
Hoogleraar Hospital and Clinical Pharmacy, UMCG, RUG Groningen
Verified email at
Cited by
Cited by
Biodistribution of 89Zr‐trastuzumab and PET Imaging of HER2‐Positive Lesions in Patients With Metastatic Breast Cancer
EC Dijkers, TH Oude Munnink, JG Kosterink, AH Brouwers, PL Jager, ...
Clinical Pharmacology & Therapeutics 87 (5), 586-592, 2010
Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
PJ Perik, MN Lub-De Hooge, JA Gietema, WT Van der Graaf, MA de Korte, ...
J Clin Oncol 24 (15), 2276-82, 2006
Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents
RJM Brüggemann, JWC Alffenaar, NMA Blijlevens, EM Billaud, ...
Clinical Infectious Diseases 48 (10), 1441-1458, 2009
Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging
ECF Dijkers, JGW Kosterink, AP Rademaker, LR Perk, ...
Journal of nuclear medicine 50 (6), 974-981, 2009
Preclinical characterisation of 111In‐DTPA‐trastuzumab
MN Lub‐de Hooge, JGW Kosterink, PJ Perik, H Nijnuis, L Tran, J Bart, ...
British journal of pharmacology 143 (1), 99-106, 2004
Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies
AGTT van Scheltinga, GM van Dam, WB Nagengast, V Ntziachristos, ...
Journal of Nuclear Medicine 52 (11), 1778-1785, 2011
The influence that electronic prescribing has on medication errors and preventable adverse drug events: an interrupted time-series study
JE van Doormaal, PMLA van den Bemt, RJ Zaal, ACG Egberts, ...
Journal of the American Medical Informatics Association 16 (6), 816-825, 2009
Applications of stable isotopes in clinical pharmacology
RCA Schellekens, F Stellaard, HJ Woerdenbag, HW Frijlink, ...
British journal of clinical pharmacology 72 (6), 879-897, 2011
Medication errors: the impact of prescribing and transcribing errors on preventable harm in hospitalised patients
JE Van Doormaal, PMLA van den Bemt, PGM Mol, RJ Zaal, ACG Egberts, ...
BMJ Quality & Safety 18 (1), 22-27, 2009
Renal handling of technetium-99m DMSA: evidence for glomerular filtration and peritubular uptake.
MJ de Lange, DA Piers, JG Kosterink, WH Van Luijk, S Meijer, ...
Journal of nuclear medicine: official publication, Society of Nuclear …, 1989
Preventable and non-preventable adverse drug events in hospitalized patients
AB Dequito, PGM Mol, JE van Doormaal, RJ Zaal, PMLA van den Bemt, ...
Drug safety 34 (11), 1089-1100, 2011
Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients
MS Bolhuis, R van Altena, D van Soolingen, WCM de Lange, DRA Uges, ...
European Respiratory Journal 42 (6), 1614-1621, 2013
Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis
N Alsaad, R van Altena, AD Pranger, D van Soolingen, WCM de Lange, ...
European Respiratory Journal 42 (2), 504-512, 2013
Voriconazole metabolism is influenced by severe inflammation: a prospective study
A Veringa, M ter Avest, LFR Span, ER van den Heuvel, DJ Touw, ...
Journal of Antimicrobial Chemotherapy 72 (1), 261-267, 2016
Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis
N Alsaad, B Wilffert, R van Altena, WCM de Lange, TS van der Werf, ...
European Respiratory Journal 43 (3), 884-897, 2014
Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients
JWC Alffenaar, R van Altena, IM Harmelink, P Filguera, E Molenaar, ...
Clinical pharmacokinetics 49 (8), 559-565, 2010
Limited sampling strategies for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis
JWC Alffenaar, JGW Kosterink, R van Altena, TS van der Werf, DRA Uges, ...
Therapeutic drug monitoring 32 (1), 97-101, 2010
Measurement of tumor VEGF-A levels with 89Zr-bevacizumab PET as an early biomarker for the antiangiogenic effect of everolimus treatment in an ovarian cancer xenograft model
ARM van der Bilt, AGTT van Scheltinga, H Timmer-Bosscha, CP Schröder, ...
Clinical cancer research 18 (22), 6306-6314, 2012
Cost-effectiveness of an electronic medication ordering system (CPOE/CDSS) in hospitalized patients
KM Vermeulen, JE van Doormaal, RJ Zaal, PGM Mol, AW Lenderink, ...
International journal of medical informatics 83 (8), 572-580, 2014
Gastrointestinal pH and transit time profiling in healthy volunteers using the IntelliCap system confirms ileo-colonic release of ColoPulse tablets
JM Maurer, RCA Schellekens, HM Van Rieke, C Wanke, V Iordanov, ...
PLoS One 10 (7), e0129076, 2015
The system can't perform the operation now. Try again later.
Articles 1–20